HAL (France)open access
Radiotherapy with twice weekly Gemcitabine and Cisplatin compared to Cisplatin alone for organ preservation in muscle-invasive bladder cancer: results of the GETUG V04 randomized phase II trial
0, Trimodal therapy TMT, 1, Muscle-invasive bladder cancer MIBC, Concurrent chemoradiotherapy CCRT
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 231578
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.